PATENT CLAIM ANALYSIS

Application Number: 16096119
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "023000"]

Abstract:
Disclosed are an amine solvate of a sodium-glucose linked transporter (SGLT) inhibitor, and a preparation method and application thereof. The SGLT inhibitor is (1S,2S,3S,4R,5S)-5-(3-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-4-ethylbenzyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol. Further provided is a crystalline compound of the amine solvate, a pharmaceutical composition comprising the amine solvate, and an application of the amine solvate in preparing an SGLT-inhibiting pharmaceutical product.

Claim (Index 18):
A method for treating diabetes, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, insulin resistance, hyperglycemia, hyperinsulinemia, elevated levels of fatty acids or glycerol, hyperlipidemia, obesity, hypertriglyceridemia, X syndrome, diabetes complications, atherosclerosis or hypertension, comprising administrating a therapeutically effective amount of the amine solvate of the compound of formula (I) according to  claim 1  or the pharmaceutical composition according to  claim 11  to a patient in need thereof.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 97.0
- Lexical Diversity: 1.78431
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15778220', '15748283', '15314458', '16065544', '15753993']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7352431365976683
- 35 USC 102 Novelty (BERT): 0.5220271197291024
- Combined Prediction Score: 0.7139215349108117
- Mean Citation Score: 275.562144
- Max Citation Score: 309.48706
- Similarity Product: 233.5631157463717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test